Alexion OneSource CoPay Program - Ultomiris
Alexion (AstraZeneca Rare Disease) · Ultomiris
Patient pays: covers out-of-pocket medication costs up to $15,000 per calendar year
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Ultomiris assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Ultomiris help that still works on Medicare or Medicaid - the programs copay cards leave out.
Ultomiris (ravulizumab-cwvz) is a long-acting terminal complement inhibitor (c5) made by Alexion (AstraZeneca Rare Disease). It is commonly prescribed for: Paroxysmal nocturnal hemoglobinuria (PNH), Atypical hemolytic uremic syndrome (aHUS), Generalized myasthenia gravis (gMG, AChR antibody-positive), Neuromyelitis optica spectrum disorder (NMOSD).
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Alexion (AstraZeneca Rare Disease) · Ultomiris
Patient pays: covers out-of-pocket medication costs up to $15,000 per calendar year
commercial insurance
Alexion (AstraZeneca Rare Disease) · Ultomiris
uninsured · underinsured
We couldn’t confirm the current terms - call the program to verify.
Common questions